Added to YB: 2025-11-21
Pitch date: 2025-11-19
HIMS [neutral]
Hims & Hers Health, Inc.
-44.73%
current return
Author Info
Asymmetric Investing analyzes stocks that have an asymmetric return potential of 10x (or more) over the next decade. Sign up for the newsletter.
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$3.7B
Pitch Price
$36.78
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.69
P/E
32.11
EV/Sales
1.83
Sector
Health Care Providers and Services
Category
growth
Results Are In! Hims & Hers Labs Is Disruption In Action
HIMS (update): New lab testing service ($499 vs $1,220 direct Quest cost) creates stickiness & opens new verticals. Quick signup/results, comprehensive biomarkers, actionable health insights. Opportunity to integrate wearables, nutrition tracking, build holistic relationships beyond prescriptions. Scale advantage over competitors like Superpower/Function in massive TAM.
Read full article (5 min)